What better way to spread Food Allergy Love than by protection for your loved ones? The makers of Auvi-Q shared with us that their revolutionary device will be available for prescription on February 14, 2017!
They are also rolling out a groundbreaking access program Auvi-q AffordAbility, which will help nearly everyone gain access, even if their insurance is reluctant, they have a high deductible, or if they are uninsured. Check it out!
PP-AQ-US-0237-AUVI-Q-Availability-FAQs3513 PP-AQ-US-0206-AUVI-Q-Patient-Pricing-Infogram-313 1.18-PP-AQ-US-0162_AQ-Launch-Announcement-Press-Release-Final-5313
The real cost is really 4,500…isn’t that the real
Issue….Mylan has the same patient assistant programs…
https://www.google.com/amp/www.forbes.com/sites/matthewherper/2017/01/19/epipen-competitor-auvi-q-to-be-free-for-most-patients-but-cost-4500-for-insurers-in-rube-goldberg-scheme/
Mylan has assistance programs that (until the firestorm) they made very little effort to tell anyone about–and from what I’ve heard from others, getting qualified can take months. The 48 hours kaleo published for their direct-delivery service includes processing time (intended time, anyway). Kaleo is hoping to prove to insurers that there is a large demand for the Auvi-Q, by bypassing them entirely if necessary. Nobody ever pays the list price of a drug, it’s the starting point for negotiations–and the cash price is going to be $360 even if you don’t qualify for any programs. I’ll admit the insurer price sounds high to start with, and I don’t know any details behind that decision.
Certainly there’s all sorts of wackiness in the pharmaceutical industry. I imagine factors such as list price, copays, out-of-pocket costs, and other things will likely evolve as kaleo gets a firmer foothold in the auto-injector market. For allergic patients everywhere, and for them (a small pharma company based on the needs of the allergic public, not a pharmaceutical giant) I hope this all works out and remains affordable in the years to come!
Agree…you just said said no one ever pays full price there is wacky stuff with the industry….so what was the up roar over the summer…600 mylan or 4500 kaleo sounds fishy to me…and Mylan’s cash is 300…Most people receiving Epipen never paid anything let alone full price like you stated. I also want those that need an autoinjector to have access no matter what device they receive. J have a good allergic child-egg and peanut allergy. Factors such as price copays, etc. play a factor in any medicine you receive
Much like we all asked Mylan last summer why not just drop the price…kaleo why not just charge insurance companies 360….why charge them 4500-why…because someone has to pay for it….
Except that people WERE paying full price last summer, and have been continuing to, when high deductible plans didn’t pass any discounts or negotiated prices on to them. Fortunately, we didn’t have to pay full price–I carry epinephrine for three people, and when you consider that we need sets for the boys at school, we have to buy 5 sets per year. I saw plenty of people sharing their receipts with way-too-high prices for the EpiPen. Kaleo is capping the cash price at $360, and making sure that 95% of Americans won’t have to pay that price. (I have no idea how it works to have separate list prices and cash prices, so don’t ask.) I don’t know what the $4500 list price for insurers is going to mean, but I do know that they’ve been working very hard to make this drug accessible.